Dysregulated integrin signalling appears in junctional epidermolysis bullosa due to mutations in laminin 332, COL17A1, or integrin α6β4, leading to YAP suppression as a part of its pathological development [14,41,81]. This evidence concerns the gene YAP1 and epidermolysis bullosa.